Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-15-068711
Filing Date
2015-12-01
Accepted
2015-12-01 08:30:11
Documents
2
Period of Report
2015-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v425957_6k.htm 6-K 98183
2 GRAPHIC xtllogo.jpg GRAPHIC 17461
  Complete submission text file 0001144204-15-068711.txt   123387
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 151261245
SIC: 2834 Pharmaceutical Preparations